ABEO 10-Q: SEC filing

Abeona Therapeutics Inc.

Filed with the SEC on · accession 0001493152-26-050738

ABEO filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -39.1% by the first close after the filing.

Summary of the filing

Abeona Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including product and license revenue, operating expenses, and balance sheet data.

Key details

FilerAbeona Therapeutics Inc.

How ABEO stock reacted

Close before

$4.17

Nov 6, 2026

First close after

-39.09%

$2.54

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ABEO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABEO?

Click here

Frequently asked questions

What did ABEO file with the SEC on Nov 9, 2026?

ABEO filed a 10-Q (SEC filing). Abeona Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including product and license revenue, operating expenses, and balance sheet data.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ABEO stock react to this filing?

ABEO closed at $4.17 before the filing and $2.54 on Nov 9, 2026 (-39.09%).

Other ABEO SEC filings

Get alerts when ABEO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days